GPC3-targeted CAR-T(The Second Affiliated Hospital of Army Medical University)

GPC3靶向CAR-T（陆军军医大学第二附属医院）

Report date: 2026/05/22 20:01:29

Base Information

Drug NameGPC3-targeted CAR-T(The Second Affiliated Hospital of Army Medical University)

Drug Alias NameAnti-GPC3 Chimeric T Cellsanti-GPC3 CAR-T

ClassificationCell and gene therapy > Cell therapy > Immune system cell therapy > Lymphocytes therapy > T-lymphocyte cell therapy > Chimeric antigen receptor T cell therapyCell and gene therapy > Cell therapy > Donor > AutologousCell and gene therapy > Gene therapy > Viral vector-based gene therapy > Retroviral vector

Mechanisms of ActionGlypican-3 modulators

TargetsGlypican-3

Therapy Area/IndicationsCarcinoma, Hepatocellular

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryMainland China

CombinationsNo

Global Highest StatusPending (Phase 2 Clinical)

Highest Status in ChinaPending

Originator CompaniesThe Second Affiliated Hospital of Army Medical University

China Registration ClassN/A

Develop Information

Active CompaniesN/A

Inactive CompaniesThe Second Affiliated Hospital of Army Medical University

Active IndicationsN/A

Inactive IndicationsCarcinoma, Hepatocellular

Other Information

ATC CodeN/A